Issue link: https://viewer.e-digitaledition.com/i/1080513
CONTINUED ON PAGE 10 PEOPLE WITH DOWN SYNDROME ARE HIGHLY PROTECTED FROM MOST SOLID TUMOR CANCERS, AND YET THEY ARE HIGHLY PREDISPOSED TO CERTAIN BLOOD CANCERS. STUDYING PEOPLE WITH DOWN SYNDROME MAY LEAD TO NEW CANCER TREATMENTS THAT COULD BENEFIT EVERYONE. Down Syndrome Research Could Provide Important Insights Into Cancer Treatments ACCORDING TO THE AMERICAN CANCER SOCIETY, an estimated 1,762,450 new cases of cancer will be diagnosed in 2019. There are hundreds of types of cancers and different ways to categorize them. One way to categorize cancer is into two types — solid tumor cancers and blood, or hematological, cancers. People with Down syndrome are highly protected from most solid tumor cancers, such as breast, uterine, and prostate cancers. However, people with Down syndrome are much more likely to develop certain leukemias, one of the key blood cancers found predominantly in children. IN SEARCH OF ANSWERS World-renowned cancer researcher Joaquín Espinosa, Ph.D., Executive Director of the Linda Crnic Institute for Down Syndrome, has studied cancer biology for years. He was an early career scientist of the Howard Hughes Medical Institute before a grant from the Global Down Syndrome Foundation opened his eyes to the broad implications of investigating the connection between cancer and Down syndrome. "My mentor, Tom Blumenthal, was the director of the Crnic Institute and insisted I apply for a grant," says Dr. Espinosa. "I Featured: Self-advocate Katherine. Photo Credit: Flashes of Hope 2018 ISSUE 4 OF 4 • DOWN SYNDROME WORLD ™ 8

